4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Malaria remains a significant global health challenge, driven by increasing Plasmodium parasite resistance to existing antimalarial drugs.
• The need for novel antiplasmodial agents targeting both sexual and asexual parasite stages is critical for effective disease prevention and treatment.

Purpose of the Study:

• To synthesize and evaluate a series of 4-substituted thieno[3,2-d]pyrimidines as novel antimalarial agents.
• To identify compounds with potent in vitro activity against both the erythrocytic stage of Plasmodium falciparum and the hepatic stage of Plasmodium berghei.

Main Methods:

• Structure-activity relationship (SAR) studies based on the Gamhepathiopine scaffold.
• Synthesis of 4-substituted thieno[3,2-d]pyrimidines via nucleophilic aromatic substitution and palladium-catalyzed coupling reactions.
• In vitro evaluation of compound activity against erythrocytic P. falciparum and hepatic P. berghei, alongside assessment of HepG2 cell toxicity.

Main Results:

• Twenty-eight novel 4-substituted thieno[3,2-d]pyrimidine derivatives were synthesized and screened.
• The chloro analogue of Gamhepathiopine exhibited potent in vitro activity against the erythrocytic stage of P. falciparum.
• This analogue also displayed improved activity against hepatic P. berghei parasites compared to the parent compound, with moderate toxicity to HepG2 cells.

Conclusions:

• 4-substituted thieno[3,2-d]pyrimidines represent a promising class of compounds for antimalarial drug development.
• The identified chloro analogue warrants further investigation as a potential lead compound for new antimalarial therapies targeting multiple parasite stages.